Rare diseases
Investigational molecules
Locations
Back to France342 clinical trials in Nimes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
FranceStudy on the Effectiveness of BP1.4979 for Adults with Essential Tremor
FranceStudy Comparing the Safety and Immune Response of the Investigational vYF Vaccine and Stamaril for Yellow Fever in Adults in Europe and Asia
FranceStudy on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
FranceStudy of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis
FranceStudy on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse
FranceStudy on the Use of 64Cu-PSMA I&T to Detect Lymph Node Spread in Men with Newly Diagnosed Prostate Cancer Before Surgery
FranceStudy on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer
FranceFranceStudy on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery
FranceStudy on Monitoring Anticoagulant Therapy with Rivaroxaban and Warfarin in Patients with Acute Coronary Syndrome and Atrial Fibrillation
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on cardiovascular conditions and metabolic disorders, examining new therapeutic approaches for heart and diabetes-related complications.
Studies evaluating novel drug combinations and monitoring strategies to improve patient outcomes.
Advanced research in cancer treatment, with particular focus on innovative therapies for various types of cancer.
Trials exploring new treatment combinations and diagnostic approaches for better patient care.
Comprehensive research into multiple sclerosis and other neurological conditions, testing innovative treatment approaches.
Focus on developing targeted therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
